Automation of the Radiosynthesis of Six Different 18F-labeled radiotracers on the AllinOne

被引：27

作者：

Li S. ^{[1
]}

Schmitz A. ^{[1
]}

Lee H. ^{[1
]}

Mach R.H. ^{[1
]}

机构：

[1] Department of Radiology, University of Pennsylvania, Philadelphia, PA

来源：

EJNMMI Radiopharmacy and Chemistry | / 1卷 / 1期

关键词：

AllinOne; Automation; F-Gln; FTP; FTT; HPLC; ISO-1; PET; Radiotracer; SPE;

D O I：

10.1186/s41181-016-0018-0

中图分类号：

学科分类号：

摘要：

Background: Fast implementation of positron emission tomography (PET) into clinical and preclinical studies highly demands automated synthesis for the preparation of PET radiopharmaceuticals in a safe and reproducible manner. The aim of this study was to develop automated synthesis methods for these sixF-labeled radiopharmaceuticals produced on a routine basis at the University of Pennsylvania using the AllinOne synthesis module. Results: The development of automated syntheses with varying complexity was accomplished including HPLC purification, SPE procedures and final formulation with sterile filtration. The six radiopharmaceuticals were obtained in high yield and high specific activity with full automation on the AllinOne synthesis module under current good manufacturing practice (cGMP) guidelines. Conclusion: The study demonstrates the versatility of this synthesis module for the preparation of a wide variety of F-labeled radiopharmaceuticals for PET imaging studies. © 2016, The Author(s).

引用

共 43 条

[1]

Aerts J., Et al., Guidance on current good radiopharmacy practice for the small‐scale preparation of radiopharmaceuticals using automated modules: a European perspective, J Label Compd Radiopharm, 57, pp. 615-620, (2014)

[2]

Bergmann S.R., Et al., Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography, J Am Coll Cardiol, 14, pp. 639-652, (1989)

[3]

Bois F., Et al., Evaluation of [18F]-(-)-norchlorofluorohomoepibatidine ([18F]-(-)-NCFHEB) as a PET radioligand to image the nicotinic acetylcholine receptors in non-human primates, Nucl Med Biol, 42, pp. 570-577, (2015)

[4]

Brooks A.F., Et al., Late-stage [18F]Fluorination: New Solutions to Old Problems, Chem Sci, 5, pp. 4545-4553, (2014)

[5]

Dehdashti F., Et al., Assessment of cellular proliferation in tumors by PET using [18F]ISO-1, J Nucl Med, 54, pp. 350-357, (2013)

[6]

Edmonds C.E., Et al., [18F]FluorThanatrace uptake as a marker of PARP1 expression and activity in breast cancer, Am J Nucl Med Mol Imaging, 6, (2016)

[7]

Gallezot J.D., Et al., Evaluation of the sensitivity of the novel alpha4beta2* nicotinic acetylcholine receptor PET radioligand [18F]-(-)-NCFHEB to increases in synaptic acetylcholine levels in rhesus monkeys, Synapse, 68, pp. 556-564, (2014)

[8]

Gruner J.M., Et al., Brain perfusion CT compared with [15 O]H 2O-PET in healthy subjects, EJNMMI Res, 1, (2011)

[9]

Hockley B.G., Et al., (-)-[18F]Flubatine: evaluation in rhesus monkeys and a report of the first fully automated radiosynthesis validated for clinical use, J Labelled Comp Radiopharm, 56, pp. 595-599, (2013)

[10]

I Sachinidis J., Poniger S., J Tochon-Danguy H., Automation for optimised production of fluorine-18-labelled radiopharmaceuticals, Curr Radiopharm, 3, pp. 248-253, (2010)

← 1 2 3 4 5 →